PWA
NTLA icon

Physician Wealth Advisors’s Intellia Therapeutics NTLA Stock Holding History

Physician Wealth Advisors’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$694 Buy
+41
New +$574 ﹤0.01% 1966
2025
Q2 		– Sell
-111
Closed -$790 – 1924
2025
Q1 		$790 Buy
+111
New +$1.12K ﹤0.01% 1236

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Physician Wealth Advisors's NTLA Position: Q2 2026 in Review

Physician Wealth Advisors opened a new position in Intellia Therapeutics (NTLA) in Q2 2026: 41 shares worth $694. The stake represents ﹤0.01% of the portfolio and ranks #1966 among its holdings. This is a return to the name: Physician Wealth Advisors previously reported a position in NTLA as recently as Q1 2025.

Physician Wealth Advisors first reported a position in NTLA in Q1 2025 and has held it in 2 quarters since. The position peaked at $790 in Q1 2025. 329 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • Physician Wealth Advisors held 41 shares of Intellia Therapeutics worth $694 as of Q2 2026.
  • Intellia Therapeutics was a new Physician Wealth Advisors position in Q2 2026.
  • Intellia Therapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1966 holding.
  • Physician Wealth Advisors first reported a position in Intellia Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • Physician Wealth Advisors's Intellia Therapeutics position peaked at $790 in Q1 2025.
  • 329 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.